Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010. - Institut Pasteur Access content directly
Journal Articles Journal of Translational Medicine Year : 2011

Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010.

Kelly da Costa
  • Function : Author
  • PersonId : 922276
Marit van Gils
  • Function : Author
  • PersonId : 922277
Katja Klein
  • Function : Author
  • PersonId : 922279
Luisa Madeira
  • Function : Author
  • PersonId : 922280
Paolo Palma
  • Function : Author
  • PersonId : 922282
Katharina Raue
  • Function : Author
  • PersonId : 922283
Marc Reudelsterz
  • Function : Author
  • PersonId : 922285
Janna Seifried
  • Function : Author
  • PersonId : 922287
Katrein Schäfer
  • Function : Author
  • PersonId : 922288
Enas Sheik-Khalil
  • Function : Author
  • PersonId : 922289
Annette Sköld
  • Function : Author
  • PersonId : 922290
Hannes Uchtenhagen
  • Function : Author
  • PersonId : 922291
Serena Ziglio
  • Function : Author
  • PersonId : 922293
Gabriella Scarlatti
  • Function : Author
  • PersonId : 922294
Robin Shattock
  • Function : Author
  • PersonId : 922295
Frances Gotch
  • Function : Author
  • PersonId : 922297

Abstract

Novel, exciting intervention strategies to prevent infection with HIV have been tested in the past year, and the field is rapidly evolving. EUROPRISE is a network of excellence sponsored by the European Commission and concerned with a wide range of activities including integrated developmental research on HIV vaccines and microbicides from discovery to early clinical trials. A central and timely theme of the network is the development of the unique concept of co-usage of vaccines and microbicides. This review, prepared by the PhD students of the network captures much of the research ongoing between the partners. The network is in its 5th year and involves over 50 institutions from 13 European countries together with 3 industrial partners; GSK, Novartis and Sanofi-Pasteur. EUROPRISE is involved in 31 separate world-wide trials of Vaccines and Microbicides including 6 in African countries (Tanzania, Mozambique, South Africa, Kenya, Malawi, Rwanda), and is directly supporting clinical trials including MABGEL, a gp140-hsp70 conjugate trial and HIVIS, vaccine trials in Europe and Africa.
Fichier principal
Vignette du fichier
1479-5876-9-40.pdf (228.18 Ko) Télécharger le fichier
1479-5876-9-40.xml (92.42 Ko) Télécharger le fichier
Origin Publisher files allowed on an open archive
Format Other
Loading...

Dates and versions

pasteur-00679111 , version 1 (14-03-2012)

Identifiers

Cite

Sarah Brinckmann, Kelly da Costa, Marit van Gils, David Hallengärd, Katja Klein, et al.. Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010.. Journal of Translational Medicine, 2011, 9 (1), pp.40. ⟨10.1186/1479-5876-9-40⟩. ⟨pasteur-00679111⟩

Collections

PASTEUR
438 View
1002 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More